This work is licensed under a Creative Commons Attribution 4.0 International License.
Fowlicidin-1 (3-21)
General Information
DRACP ID DRACP03870
Peptide Name Fowlicidin-1 (3-21)
Sequence KRVWPLVIRTVIAGYNLYR
Sequence Length 19
UniProt ID Q6QLQ5
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C110H177N31O24
Absent amino acids CDEFHMQS
Common amino acids RV
Mass 263905
Pl 11.47
Basic residues 4
Acidic residues 0
Hydrophobic residues 9
Net charge 4
Boman Index -2292
Hydrophobicity 20.53
Aliphatic Index 133.16
Half Life
Mammalian: 1 hour
Yeast: 2 min
E.coli: 2 min
Extinction Coefficient cystines 8480
Absorbance 280nm 471.11
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31473417
Title The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities
Doi Not available
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 13893
This work is licensed under a Creative Commons Attribution 4.0 International License.